PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Apr-2020 Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer Amphista Therapeutics
06-Apr-2020 FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Potential Treatment for COVID-19 Ridgeback Biotherapeutics LP
06-Apr-2020 RTI International acquires Medical Data Analytics RTI International
06-Apr-2020 RedHill Biopharma Announces First COVID-19 Patient Treated with Opaganib in Israel Under Compassionate Use RedHill Biopharma
06-Apr-2020 Polyplus-transfection launches FectoVIR-AAV transfection reagent for CGT development viral vector bottleneck Polyplus-transfection
06-Apr-2020 World’s leading Biobanks join BC Platforms Global Data Partner Network to Advance Personalized Healthcare Research BC Platforms
06-Apr-2020 Statement regarding Abu Dhabi Commercial Bank NMC Health plc
06-Apr-2020 Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme Ergomed plc
06-Apr-2020 Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy Izana Bioscience
06-Apr-2020 iReceptor Plus to Offer Tools and Infrastructure for Sharing Antibody and T-cell Receptor Sequencing Data From COVID-19 Patients iReceptor Plus
06-Apr-2020 Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test Co-Diagnostics
06-Apr-2020 Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test Co-Diagnostics
06-Apr-2020 Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test Co-Diagnostics
06-Apr-2020 Global Infusion Pumps and Accessories Market Research Report | Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co., Smiths Medical, Johnson & Johnson, Becton, Dickinson and Company, ICU Medical, Inc., CME Medical UK Limited, Moog, Inc., and Terumo Corporation Ricerca Alfa
06-Apr-2020 OxThera Announces Completion of Recruitment in Phase 3 ePHex Study With Oxabact® in Patients With Primary Hyperoxaluria OxThera
06-Apr-2020 Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment Samsung Biologics
03-Apr-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
03-Apr-2020 Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market BioArdis LLC
03-Apr-2020 Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline Servier
03-Apr-2020 Availability of Preparatory Documents for the Combined General Meeting of May 27, 2020 Transgene